The Independent Voice of
European Private Equity

Advanced Search

Kurma Partners sells Amolyt Pharma

Silvia Iacovcich 14 March 2024

Kurma Partners has sold Amolyt Pharma to AstraZeneca.

Amolyt Pharma is a clinical-stage biotechnology company that develops new treatments for rare endocrine diseases.

Next article »

« Previous article

Related Articles

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24

Archimed-backed Carso bolts on three firms, focuses on European expansion

07/05/24

Innova closes seventh fund above hard-cap on €407m

07/05/24

Rockpool backs Scottish software testing firm 2i

07/05/24

Abris exits Scanmed in trade sale

07/05/24